Treatment of Adults With Growth Hormone Deficiency

Inclusion Criteria: * Patients (male and female) who have completed the Visit 8 of preceding main study (BPLG-005) and are willing to continue their participation in an extension study * If female, women of child-bearing potential who are using a reliable method of contraception and be willing to use it throughout the study. A negative urine pregnancy test at Visit 0 is required for females of child-bearing potential * Written informed consent of the patient Exclusion Criteria: * Evidence of active malignancy or growth of a previously stable tumor * Benign intracranial hypertension * Clinically significant respiratory, cardiac, hepatic, renal, neuromuscular disease * Non-compliance with medications, un-cooperativeness or drug abuse during the BPLG-005 study * Patients who are not able to comply with the study protocol for any reason